Mechanism of Chinese herbal medicine delaying glomerulosclerosis in diabetic nephropathy

Zhongguo Zhongyao Zazhi

Volumn 35, Issue 4, 2010, Pages 525-530

  Chen, Jing ^a   Wan, Yigang ^b   Bian, Rongwen ^c   Gu, Liubao ^c   Wang, Chaojun ^a   Zhang, Huilan ^a   Yao, Jian ^d  

^a NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

^b MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^c Jiangsu Province Institute of Geriatrics   (China)

^d UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

Chinese herbal medicine; Diabetic nephropathy; Pharmacological mechanism

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ANGIOTENSIN II; CHINESE DRUG; CONNECTIVE TISSUE GROWTH FACTOR; CYTOKINE; DIPEPTIDYL CARBOXYPEPTIDASE; GLUCOSE TRANSPORTER 1; GUI QI; HERBACEOUS AGENT; INTERCELLULAR ADHESION MOLECULE 1; KEISHI BUKURYO GAN; MONOCYTE CHEMOTACTIC PROTEIN 1; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NEPHRIN; PLATELET DERIVED GROWTH FACTOR; PODOCALYXIN; PODOCIN; REACTIVE OXYGEN METABOLITE; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ALLOXAN DIABETES MELLITUS; ARTICLE; CHINESE MEDICINE; DIABETIC NEPHROPATHY; DISEASE COURSE; DRUG MECHANISM; EXTRACELLULAR MATRIX; FIBROGENESIS; GLOMERULOSCLEROSIS; GLOMERULUS BASEMENT MEMBRANE; HERBAL MEDICINE; HUMAN; INFLAMMATION; KIDNEY FIBROSIS; NONHUMAN; OXIDATIVE STRESS; PODOCYTE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; STREPTOZOCIN DIABETES;

ANIMALS; DIABETIC NEPHROPATHIES; DRUGS, CHINESE HERBAL; GLOMERULONEPHRITIS; HUMANS; OXIDATIVE STRESS;

EID: 77952203619     PISSN: 10015302     EISSN: None     Source Type: Journal    
DOI: 10.4268/cjcmm20100427     Document Type: Article

References (42)

1. Friedman E A. The diabetic kidney [J]. N Engl J Med, 2006, 355(17): 1837.
2. Raptis A E, Viberti G. Pathogenesis of diabetic nephropathy [J]. Exp Clin Endocrinol Diabetes, 2001, 109(2): S424.
3. Qian Y, Feldman E, Pennathur S, et al. From fibrosis to sclerosis: mechanisms of glomerulosclerosis in diabetic nephropathy [J]. Diabetes, 2008, 57(6): 1439.
4. Manna P, Sinha M, Sil P C. Prophylactic role of arjunolic acid in response to streptozotocin mediated diabetic renal injury: activation of polyol pathway and oxidative stress responsive signaling cascades [J]. Chem Biol Interact, 2009, 181(3): 297.
5. Sourris K C, Forbes J M. Interactions between advanced glycation end-products (AGE) and their receptors in the development and progression of diabetic nephropathy-are these receptors valid therapeutic targets [J]. Curr Drug Targets, 2009, 10(1): 42.
6. Nakagawa T, Yokozawa T, Terasawa K, et al. Therapeutic usefulness of Keishi-bukuryo-gan for diabetic nephropathy [J]. J Pharm Pharmacol, 2003, 55(2): 219. (Pubitemid 36277760)
7. Noh H, King G L. The role of protein kinase C activation in diabetic nephropathy [J]. Kidney Int, 2007(Suppl 106): S49.
8. Brosius F C, Heilig C W. Glucose transporters in diabetic nephropathy [J]. Pediatr Nephrol, 2005, 20(4): 447.
9. Zheng J M, Zhu J M, Li L S, et al. Rhein reverses the diabetic phenotype of mesangial cells over-expressing the glucose transporter (GLUT1) by inhibiting the hexosamine pathway [J]. Br J Pharmacol, 2008, 153(7): 1456.
10. Ziyadeh F N, Wolf G. Pathogenesis of the podocytopathy and proteinuria in diabetic glomerulopathy [J]. Curr Diabetes Rev, 2008, 4(1): 39. (Pubitemid 351210971)
11. Zhang P, Zhang J J, Su J, et al. Effect of total glucosides of paeony on the expression of nephrin in the kidneys from diabetic rats [J]. Am J Chin Med, 2009, 37(2): 295.
12. Economou C G, Kitsiou P V, Tzinia A K, et al. Enhanced podocalyxin expression alters the structure of podocyte basal surface [J]. J Cell Sci, 2004, 117(15): 3281.
13. Perkins B A, Aiello L P, Krolewski A S. Diabetes complications and the renin-angiotensin system [J]. N Engl J Med, 2009, 361(1): 83.
14. Zhang Y W, Xie D, Chen Y X, et al. Protective effect of Gui Qi mixture on the progression of diabetic nephropathy in rats [J]. Exp Clin Endocrinol Diabetes, 2006, 114(10): 563. (Pubitemid 46087262)
15. Wang Q Y, Guan Q H, Chen F Q. The changes of platelet-derived growth factor-BB (PDGF-BB) in T2DM and its clinical significance for early diagnosis of diabetic nephropathy [J]. Diabetes Res Clin Pract, 2009, 85(2): 166.
16. Ziyadeh F N. Different roles for TGF-beta and VEGF in the pathogenesis of the cardinal features of diabetic nephropathy [J]. Diabetes Res Clin Pract, 2008, 82(Suppl 1): S38.
17. Ito Y, Aten J, Bende R J, et al. Expression of connective tissue growth factor in human renal fibrosis [J]. Kidney Int, 1998, 53(4): 853.
18. Zhang Y W, Xie D, Xia B, et al. Suppression of transforming growth factor-beta1 gene expression by Danggui Buxue Tang, a traditional Chinese herbal preparation, in retarding the progress of renal damage in streptozotocin- induced diabetic rats [J]. Horm Metab Res, 2006, 38(2): 82.
19. Xu H Q, Hao H P. Effects of iridoid total glycoside from Cornus officinalis on prevention of glomerular overexpression of transforming growth factor beta 1 and matrixes in an experimental diabetes model [J]. Biol Pharm Bull, 2004, 27(7): 1014.
20. Ha H, Hwang I A, Park J H, et al. Role of reactive oxygen species in the pathogenesis of diabetic nephropathy [J]. Diabetes Res Clin Pract, 2008, 82(1): S42.
21. Yokozawa T, Yamabe N, Kim H Y, et al. Protective effects of morroniside isolated from Corni Fructus against renal damage in streptozotocin-induced diabetic rats [J]. Biol Pharm Bull, 2008, 31(7): 1422. (Pubitemid 351930661)
22. Xu H, Shen J, Liu H, et al. Morroniside and loganin extracted from Cornus officinalis have protective effects on rat mesangial cell proliferation exposed to advanced glycation end products by preventing oxidative stress [J]. Can J Physiol Pharmacol, 2006, 84(12): 1267. (Pubitemid 46707375)
23. Liu I M, Tzeng T F, Liou S S, et al. The amelioration of streptozotocin diabetes-induced renal damage by Wu-Ling-San (Hoelen Five Herb Formula), a traditional Chinese prescription [J]. J Ethnopharmacol, 2009, 124(2): 211.
24. Tuttle K R. Linking metabolism and immunology: diabetic nephropathy is an inflammatory disease [J]. J Am Soc Nephrol, 2005, 16(6): 1537.
25. Qi X M, Wu G Z, Wu Y G, et al. Renoprotective effect of breviscapine through suppression of renal macrophage recruitment in streptozotocin-induced diabetic rats [J]. Nephron Exp Nephrol, 2006, 104(4): e147.
26. Yamamoto H, Uchigata Y, Okamoto H. Streptozotocin and alloxan induce DNA strand breaks and poly (ADP-ribose) synthetase in pancreatic islets [J]. Nature, 1981, 294(5838): 284. (Pubitemid 12221500)
27. Roesler W J, Pugazhenthi S, Khandelwal R L. Hepatic glycogen metabolism in the db/db mouse [J]. Mol Cell Biochem, 1990, 92(2): 99.
28. Utimura R, Fujihara C K, Mattar A L, et al. Mycophenolate mofetil prevents the development of glomerular injury in experimental diabete [J]. Kidney Int, 2003, 63(1): 209. (Pubitemid 35463923)